Nvidia CEO Jensen Huang Visits Beijing After Trump Administration’s Ban On H20 Chip Sales To China

Nvidia Corp. CEO Jensen Huang arrived in Beijing on Thursday at the invitation of a domestic trade group amid an escalating trade war between the U.S. and China.

Huang stressed the importance of the Chinese market for the chip designing company, according to a Financial Times report that cited state broadcaster CCTV.

The AI bellwether’s CEO expressed hope that Nvidia and Chinese authorities could “continue co-operating,” according to the broadcaster.

Huang’s visit comes right after the U.S. expanded export restrictions on China and D5 countries to include Nvidia’s H20 AI chip.

Before this, Nvidia’s H100 and A100 chips, which are more powerful than the H20 chip, were banned from being sold in China.

This prompted Nvidia to disclose a $5.5 billion charge, resulting in a nearly 7% decline in its stock since the announcement.

The company is also facing a House panel probe, with the House of Representatives Select Committee on China Chair Rep. John Moolenaar (R-Mich.) and Ranking member Raja Krishnamoorthy (D-Ill.) asking Nvidia to explain how its advanced AI chips ended up in the hands of DeepSeek, which launched new large-language models in January this year.

This comes at a time when the U.S. and China are engaged in a trade war, following the Trump administration's announcement of reciprocal tariffs on Chinese goods imported into the U.S.; the Xi Jinping administration has retaliated with tariffs on U.S. goods.

After a slew of hikes, Chinese goods are currently subject to 245% tariffs, while U.S. goods are subject to 125% tariffs.

Trump’s tariffs have drawn criticism from prominent Wall Street CEOs like Jamie Dimon, Ken Langone, and Larry Fink.

Federal Reserve chair Jerome Powell also expressed concerns that tariffs could drive up inflation and slow down growth, much to the chagrin of President Trump, who berated him on his social media platform, Truth Social, on Thursday.

Nvidia’s stock was marginally up by 0.01% in pre-market trading on Thursday.

For updates and corrections, email newsroom[at]stocktwits[dot]com.

Also See: Eli Lilly’s Weight Loss Pill Succeeds In Phase 3 Trials On Type-2 Diabetes Patients